AIMC Topic: Drug Repositioning

Clear Filters Showing 151 to 160 of 270 articles

Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma.

CNS oncology
Glioblastoma is a heterogeneous lethal disease, regulated by a stem-cell hierarchy and the neurotransmitter microenvironment. The identification of chemotherapies targeting individual cancer stem cells is a clinical need. A robotic workstation was ...

Artificial intelligence approach fighting COVID-19 with repurposing drugs.

Biomedical journal
BACKGROUND: The ongoing COVID-19 pandemic has caused more than 193,825 deaths during the past few months. A quick-to-be-identified cure for the disease will be a therapeutic medicine that has prior use experiences in patients in order to resolve the ...

HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.

Journal of chemical information and modeling
Drug research and development is a time-consuming and high-cost task, pressing an urgent demand to identify novel indications of approved drugs, referred to as drug repositioning, which provides an economical and efficient way for drug discovery. Wit...

Prediction of Side Effects Using Comprehensive Similarity Measures.

BioMed research international
Identifying the potential side effects of drugs is crucial in clinical trials in the pharmaceutical industry. The existing side effect prediction methods mainly focus on the chemical and biological properties of drugs. This study proposes a method th...

RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.

Scientific reports
Cancer is one of the most difficult diseases to treat owing to the drug resistance of tumour cells. Recent studies have revealed that drug responses are closely associated with genomic alterations in cancer cells. Numerous state-of-the-art machine le...

Next-generation drug repurposing using human genetics and network biology.

Current opinion in pharmacology
Drug repurposing has attracted increased attention, especially in the context of drug discovery rates that remain too low despite a recent wave of approvals for biological therapeutics (e.g. gene therapy). These new biological entities-based treatmen...

Machine and deep learning approaches for cancer drug repurposing.

Seminars in cancer biology
Knowledge of the underpinnings of cancer initiation, progression and metastasis has increased exponentially in recent years. Advanced "omics" coupled with machine learning and artificial intelligence (deep learning) methods have helped elucidate targ...

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces.

BMC bioinformatics
BACKGROUND: Detection of new drug-target interactions by computational algorithms is of crucial value to both old drug repositioning and new drug discovery. Existing machine-learning methods rely only on experimentally validated drug-target interacti...